Pharma

Fluoropolymer Linings for Industrial Corrosion Protection
Manufacturing Fluoropolymer Linings for Industrial Corrosion Protection

High-consequence chemical processing environments often subject equipment to a cocktail of aggressive acids and volatile solvents that can compromise the structural integrity of conventional metallic alloys within months of deployment. While specialized alloys like Hastelloy or titanium offer

How Will the FDA PreCheck Pilot Reshape Drug Manufacturing?
Manufacturing How Will the FDA PreCheck Pilot Reshape Drug Manufacturing?

Kwame Zaire is a veteran in the manufacturing sector who has seen the industry evolve from traditional assembly lines to the sophisticated, tech-driven environments of today. With a deep focus on production management and quality assurance, he brings a unique perspective to the intersection of

U.S. Blacklists WuXi AppTec While WuXi Biologics Is Spared
Management U.S. Blacklists WuXi AppTec While WuXi Biologics Is Spared

The biotechnology sector has transformed into a high-stakes arena of geopolitical competition as the United States intensifies its scrutiny of foreign-controlled entities in critical supply chains. Recently, the U.S. Department of Defense shifted the global landscape by including WuXi AppTec on its

How Is Engineering Redefining Pharmaceutical Development?
Manufacturing Technology How Is Engineering Redefining Pharmaceutical Development?

The pharmaceutical industry is currently grappling with an era of unprecedented molecular complexity that threatens to outpace traditional manufacturing capabilities. The traditional landscape of drug discovery has long been haunted by a staggering failure rate where nearly ninety percent of

Does U.S. Drug Manufacturing Offer a Real Speed Edge?
Management Does U.S. Drug Manufacturing Offer a Real Speed Edge?

The vulnerability of the pharmaceutical supply chain became a central concern for healthcare providers after a series of geopolitical shifts forced a re-evaluation of offshore manufacturing. When Aquestive Therapeutics received a complete response letter from the FDA regarding a design flaw in its

How Is Lonza Leading the Antibody-Drug Conjugate Revolution?
Management How Is Lonza Leading the Antibody-Drug Conjugate Revolution?

The pharmaceutical landscape has witnessed a monumental shift as precision oncology evolves from a theoretical aspiration into a standardized clinical reality that redefines how terminal illnesses are managed across the globe. Antibody-drug conjugates (ADCs) have emerged as the vanguard of this new

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later